Home » Topics » BioWorld Science

BioWorld Science
RSS

Gasherbrum Bio presents new GLP-1 receptor agonists

Aug. 30, 2021

Merck & Co. and The Walter and Eliza Hall Institute of Medical Research divulge new antimalarials

Aug. 30, 2021

Mindset Pharma discloses 5-HT2A receptor agonists

Aug. 30, 2021

Bristol Myers Squibb identifies new Toll-like receptor 7 agonists

Aug. 30, 2021

RubrYc enters license and collaboration agreements on epitope-targeted antibody therapeutics

Aug. 27, 2021

Preclinical studies characterize bispecific EGFR/CD16A NK innate cell engager AFM-24

Aug. 27, 2021

First-in-human study planned with NXP-800 in advanced cancers

Aug. 27, 2021

Data presented for Sage Therapeutics' SAGE-718 for neurological diseases

Aug. 27, 2021

Unnatural Products targets MDM2 and MDM4 with macrocylic peptides

Aug. 27, 2021

Pardes initiates phase I study of antiviral PBI-0451 for SARS-CoV-2 infection

Aug. 27, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...